Impact Biomedical Inc. (IBO)
NYSE · Healthcare
Impact Biomedical Inc. EBITDA 2022–2025
Impact Biomedical Inc. annual/quarterly ebitda history and growth rate from 2022 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Impact Biomedical Inc. ebitda for the quarter ending March 31, 2026 was -2.0 M.
- Impact Biomedical Inc. ebitda for the twelve months ending March 31, 2026 was -4.0 M.
- Impact Biomedical Inc. annual ebitda for 2025 was -3.1 M, a 36.93% increase from 2022.
- Impact Biomedical Inc. annual ebitda for 2022 was -2.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Impact Biomedical Inc. EBITDA — FAQ
Impact Biomedical Inc. (IBO) ebitda over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IBO's ebitda history?
The chart and table above show Impact Biomedical Inc.'s ebitda by year and by quarter, including the growth rate.